We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+15.1%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$331B
AUM Growth
+$17.3B
Cap. Flow
-$23.8B
Cap. Flow %
-7.19%
Top 10 Hldgs %
12.89%
Holding
5,713
New
529
Increased
2,204
Reduced
2,111
Closed
640

Sector Composition

Rank Sector Weight
1 Technology 12.24%
2 Financials 9.92%
3 Healthcare 9.06%
4 Consumer Discretionary 8.02%
5 Energy 6.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NIU
4751
Niu Technologies
NIU
$203M
$195K ﹤0.01%
24,099
-44,694
-65% -$346K
BY icon
4752
Byline Bancorp
BY
$1.78B
$194K ﹤0.01%
+10,500
New +$197K
CLBK icon
4753
Columbia Financial
CLBK
$1.12B
$194K ﹤0.01%
12,397
-12,272
-50% -$191K
RBB icon
4754
RBB Bancorp
RBB
$448M
$192K ﹤0.01%
+10,215
New +$202K
DOVA
4755
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$191K ﹤0.01%
21,534
+4,902
+29% +$39.8K
CTRC
4756
DELISTED
Centric Brands Inc. Common Stock
CTRC
$188K ﹤0.01%
+41,820
New +$163K
PCG icon
4757
CALL
PG&E
PCG
$38.3B
$187K ﹤0.01%
10,500
-926,800
-99% -$15M
CDTX
4758
DELISTED
Cidara Therapeutics
CDTX
$185K ﹤0.01%
3,495
-936
-21% -$51.3K
UUUU icon
4759
Energy Fuels
UUUU
$2.86B
$185K ﹤0.01%
55,590
+13,404
+32% +$40.4K
QTNT
4760
DELISTED
Quotient Limited Ordinary Shares
QTNT
$185K ﹤0.01%
+514
New +$181K
LX
4761
LexinFintech Holdings
LX
$241M
$184K ﹤0.01%
+17,568
New +$179K
MACK
4762
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$184K ﹤0.01%
33,572
-103
-0.3% -$473
NAC icon
4763
Nuveen California Quality Municipal Income Fund
NAC
$1.83B
$179K ﹤0.01%
12,960
-4,719
-27% -$62.8K
IVAC
4764
DELISTED
Intevac Inc
IVAC
$179K ﹤0.01%
+29,265
New +$169K
PRMW
4765
DELISTED
Primo Water Corporation
PRMW
$178K ﹤0.01%
11,500
-40,501
-78% -$584K
NOA
4766
North American Construction
NOA
$369M
$177K ﹤0.01%
+15,232
New +$169K
OTIC
4767
DELISTED
Otonomy, Inc.
OTIC
$177K ﹤0.01%
67,401
-22,591
-25% -$50.9K
BLBD icon
4768
Blue Bird Corp
BLBD
$2.35B
$176K ﹤0.01%
10,417
-701
-6% -$13.1K
PIR
4769
DELISTED
Pier 1 Imports, Inc.
PIR
$176K ﹤0.01%
11,548
+2,118
+22% +$38.2K
CLPR
4770
Clipper Realty
CLPR
$45.2M
$175K ﹤0.01%
+13,037
New +$170K
AOD
4771
abrdn Total Dynamic Dividend Fund
AOD
$1.11B
$172K ﹤0.01%
20,896
+3,231
+18% +$26.2K
STIM icon
4772
Neuronetics
STIM
$138M
$172K ﹤0.01%
+11,274
New +$187K
TTPH
4773
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$171K ﹤0.01%
6,379
-3,946
-38% -$100K
JILL icon
4774
J. Jill
JILL
$272M
$170K ﹤0.01%
6,167
-877
-12% -$22.4K
BRS
4775
DELISTED
Bristow Group, Inc.
BRS
$170K ﹤0.01%
153,531
-29,266
-16% -$63.6K

Similar funds

Goldman Sachs's Q1 2019 Portfolio in Review

As of Q1 2019, Goldman Sachs held 5,713 positions worth $331B, up 5.5% from $314B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Goldman Sachs withdrew a net $23.8B in Q1 2019, closing 640 positions and reducing 2,111 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class B, an estimated $467M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Goldman Sachs opened a new position in Fox Class B worth $104M.

  • Goldman Sachs's largest Q1 2019 buy was Fox Class B: 2,897,722 shares worth $104M.
  • Goldman Sachs added most to Pfizer in Q1 2019, an estimated $597M increase.
  • Goldman Sachs's biggest Q1 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.07B.
  • Goldman Sachs fully exited Twenty-First Century Fox, Inc. Class B in Q1 2019, selling an estimated $467M.
  • Goldman Sachs's ten largest holdings make up 13% of its $331B portfolio in Q1 2019.
  • Goldman Sachs opened 529 new positions and closed 640 in Q1 2019.
  • Goldman Sachs's portfolio value rose 5.5% quarter-over-quarter to $331B.

Based on Goldman Sachs's 13F filing for Q1 2019, filed 15 May 2019.